nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—UGT1A9—Sorafenib—liver cancer	0.36	0.637	CbGbCtD
Hydromorphone—CYP2C9—Sorafenib—liver cancer	0.0602	0.107	CbGbCtD
Hydromorphone—CYP2D6—Sorafenib—liver cancer	0.055	0.0974	CbGbCtD
Hydromorphone—CYP3A4—Sorafenib—liver cancer	0.035	0.0619	CbGbCtD
Hydromorphone—CYP2D6—Doxorubicin—liver cancer	0.0334	0.0591	CbGbCtD
Hydromorphone—CYP3A4—Doxorubicin—liver cancer	0.0212	0.0376	CbGbCtD
Hydromorphone—Fluid retention—Doxorubicin—liver cancer	0.000608	0.00219	CcSEcCtD
Hydromorphone—Dyspnoea—Sorafenib—liver cancer	0.000595	0.00214	CcSEcCtD
Hydromorphone—Dry eye—Doxorubicin—liver cancer	0.000591	0.00213	CcSEcCtD
Hydromorphone—Cramps of lower extremities—Doxorubicin—liver cancer	0.000588	0.00212	CcSEcCtD
Hydromorphone—Dyspepsia—Sorafenib—liver cancer	0.000588	0.00211	CcSEcCtD
Hydromorphone—Coma—Doxorubicin—liver cancer	0.000585	0.0021	CcSEcCtD
Hydromorphone—Decreased appetite—Sorafenib—liver cancer	0.000581	0.00209	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Sorafenib—liver cancer	0.000577	0.00207	CcSEcCtD
Hydromorphone—Fatigue—Sorafenib—liver cancer	0.000576	0.00207	CcSEcCtD
Hydromorphone—Pain—Sorafenib—liver cancer	0.000571	0.00205	CcSEcCtD
Hydromorphone—Constipation—Sorafenib—liver cancer	0.000571	0.00205	CcSEcCtD
Hydromorphone—Pulmonary oedema—Doxorubicin—liver cancer	0.00057	0.00205	CcSEcCtD
Hydromorphone—Naloxone—ESR1—liver cancer	0.000559	0.495	CrCbGaD
Hydromorphone—Gastrointestinal pain—Sorafenib—liver cancer	0.000546	0.00196	CcSEcCtD
Hydromorphone—Increased appetite—Epirubicin—liver cancer	0.000535	0.00192	CcSEcCtD
Hydromorphone—Urticaria—Sorafenib—liver cancer	0.000531	0.00191	CcSEcCtD
Hydromorphone—Abdominal pain—Sorafenib—liver cancer	0.000528	0.0019	CcSEcCtD
Hydromorphone—Body temperature increased—Sorafenib—liver cancer	0.000528	0.0019	CcSEcCtD
Hydromorphone—Anaphylactoid reaction—Epirubicin—liver cancer	0.000519	0.00187	CcSEcCtD
Hydromorphone—Lethargy—Epirubicin—liver cancer	0.000512	0.00184	CcSEcCtD
Hydromorphone—Hyponatraemia—Epirubicin—liver cancer	0.000504	0.00181	CcSEcCtD
Hydromorphone—Diplopia—Epirubicin—liver cancer	0.000502	0.00181	CcSEcCtD
Hydromorphone—Pain in extremity—Epirubicin—liver cancer	0.000502	0.00181	CcSEcCtD
Hydromorphone—Osteoarthritis—Epirubicin—liver cancer	0.000502	0.00181	CcSEcCtD
Hydromorphone—Increased appetite—Doxorubicin—liver cancer	0.000495	0.00178	CcSEcCtD
Hydromorphone—Affect lability—Epirubicin—liver cancer	0.000494	0.00178	CcSEcCtD
Hydromorphone—Migraine—Epirubicin—liver cancer	0.000494	0.00178	CcSEcCtD
Hydromorphone—Hypersensitivity—Sorafenib—liver cancer	0.000492	0.00177	CcSEcCtD
Hydromorphone—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00048	0.00173	CcSEcCtD
Hydromorphone—Asthenia—Sorafenib—liver cancer	0.000479	0.00172	CcSEcCtD
Hydromorphone—Cardiac arrest—Epirubicin—liver cancer	0.000478	0.00172	CcSEcCtD
Hydromorphone—Mood swings—Epirubicin—liver cancer	0.000476	0.00171	CcSEcCtD
Hydromorphone—Lethargy—Doxorubicin—liver cancer	0.000474	0.00171	CcSEcCtD
Hydromorphone—Pruritus—Sorafenib—liver cancer	0.000473	0.0017	CcSEcCtD
Hydromorphone—Dehydration—Epirubicin—liver cancer	0.000467	0.00168	CcSEcCtD
Hydromorphone—Hyponatraemia—Doxorubicin—liver cancer	0.000467	0.00168	CcSEcCtD
Hydromorphone—Pain in extremity—Doxorubicin—liver cancer	0.000465	0.00167	CcSEcCtD
Hydromorphone—Osteoarthritis—Doxorubicin—liver cancer	0.000465	0.00167	CcSEcCtD
Hydromorphone—Diplopia—Doxorubicin—liver cancer	0.000465	0.00167	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Epirubicin—liver cancer	0.000459	0.00165	CcSEcCtD
Hydromorphone—Abdominal pain upper—Epirubicin—liver cancer	0.000459	0.00165	CcSEcCtD
Hydromorphone—Migraine—Doxorubicin—liver cancer	0.000457	0.00165	CcSEcCtD
Hydromorphone—Affect lability—Doxorubicin—liver cancer	0.000457	0.00165	CcSEcCtD
Hydromorphone—Diarrhoea—Sorafenib—liver cancer	0.000457	0.00164	CcSEcCtD
Hydromorphone—Breast disorder—Epirubicin—liver cancer	0.000454	0.00163	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000452	0.00163	CcSEcCtD
Hydromorphone—Nasopharyngitis—Epirubicin—liver cancer	0.000449	0.00162	CcSEcCtD
Hydromorphone—Gastritis—Epirubicin—liver cancer	0.000444	0.0016	CcSEcCtD
Hydromorphone—Muscular weakness—Epirubicin—liver cancer	0.000443	0.00159	CcSEcCtD
Hydromorphone—Cardiac arrest—Doxorubicin—liver cancer	0.000442	0.00159	CcSEcCtD
Hydromorphone—Dizziness—Sorafenib—liver cancer	0.000442	0.00159	CcSEcCtD
Hydromorphone—Mood swings—Doxorubicin—liver cancer	0.00044	0.00158	CcSEcCtD
Hydromorphone—Abdominal distension—Epirubicin—liver cancer	0.000437	0.00157	CcSEcCtD
Hydromorphone—Asthma—Epirubicin—liver cancer	0.000434	0.00156	CcSEcCtD
Hydromorphone—Dysphagia—Epirubicin—liver cancer	0.000434	0.00156	CcSEcCtD
Hydromorphone—Dehydration—Doxorubicin—liver cancer	0.000432	0.00155	CcSEcCtD
Hydromorphone—Vomiting—Sorafenib—liver cancer	0.000425	0.00153	CcSEcCtD
Hydromorphone—Abdominal pain upper—Doxorubicin—liver cancer	0.000424	0.00153	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Doxorubicin—liver cancer	0.000424	0.00153	CcSEcCtD
Hydromorphone—Rash—Sorafenib—liver cancer	0.000421	0.00151	CcSEcCtD
Hydromorphone—Dermatitis—Sorafenib—liver cancer	0.000421	0.00151	CcSEcCtD
Hydromorphone—Breast disorder—Doxorubicin—liver cancer	0.00042	0.00151	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000418	0.00151	CcSEcCtD
Hydromorphone—Headache—Sorafenib—liver cancer	0.000418	0.0015	CcSEcCtD
Hydromorphone—Nasopharyngitis—Doxorubicin—liver cancer	0.000416	0.00149	CcSEcCtD
Hydromorphone—Gastritis—Doxorubicin—liver cancer	0.000411	0.00148	CcSEcCtD
Hydromorphone—Muscular weakness—Doxorubicin—liver cancer	0.00041	0.00147	CcSEcCtD
Hydromorphone—Dysuria—Epirubicin—liver cancer	0.000406	0.00146	CcSEcCtD
Hydromorphone—Abdominal distension—Doxorubicin—liver cancer	0.000404	0.00145	CcSEcCtD
Hydromorphone—Asthma—Doxorubicin—liver cancer	0.000402	0.00144	CcSEcCtD
Hydromorphone—Dysphagia—Doxorubicin—liver cancer	0.000402	0.00144	CcSEcCtD
Hydromorphone—Pollakiuria—Epirubicin—liver cancer	0.000401	0.00144	CcSEcCtD
Hydromorphone—Nausea—Sorafenib—liver cancer	0.000397	0.00143	CcSEcCtD
Hydromorphone—Weight decreased—Epirubicin—liver cancer	0.000393	0.00141	CcSEcCtD
Hydromorphone—Drowsiness—Epirubicin—liver cancer	0.000387	0.00139	CcSEcCtD
Hydromorphone—Infestation—Epirubicin—liver cancer	0.000387	0.00139	CcSEcCtD
Hydromorphone—Infestation NOS—Epirubicin—liver cancer	0.000387	0.00139	CcSEcCtD
Hydromorphone—Stomatitis—Epirubicin—liver cancer	0.000377	0.00136	CcSEcCtD
Hydromorphone—Dysuria—Doxorubicin—liver cancer	0.000376	0.00135	CcSEcCtD
Hydromorphone—Sweating—Epirubicin—liver cancer	0.000371	0.00133	CcSEcCtD
Hydromorphone—Pollakiuria—Doxorubicin—liver cancer	0.000371	0.00133	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Epirubicin—liver cancer	0.000366	0.00132	CcSEcCtD
Hydromorphone—Weight decreased—Doxorubicin—liver cancer	0.000363	0.00131	CcSEcCtD
Hydromorphone—Infestation—Doxorubicin—liver cancer	0.000358	0.00129	CcSEcCtD
Hydromorphone—Infestation NOS—Doxorubicin—liver cancer	0.000358	0.00129	CcSEcCtD
Hydromorphone—Drowsiness—Doxorubicin—liver cancer	0.000358	0.00129	CcSEcCtD
Hydromorphone—Bradycardia—Epirubicin—liver cancer	0.000354	0.00127	CcSEcCtD
Hydromorphone—Stomatitis—Doxorubicin—liver cancer	0.000349	0.00126	CcSEcCtD
Hydromorphone—Rhinitis—Epirubicin—liver cancer	0.000348	0.00125	CcSEcCtD
Hydromorphone—Hypoaesthesia—Epirubicin—liver cancer	0.000346	0.00124	CcSEcCtD
Hydromorphone—Sweating—Doxorubicin—liver cancer	0.000343	0.00123	CcSEcCtD
Hydromorphone—Urinary tract disorder—Epirubicin—liver cancer	0.000343	0.00123	CcSEcCtD
Hydromorphone—Oedema peripheral—Epirubicin—liver cancer	0.000342	0.00123	CcSEcCtD
Hydromorphone—Connective tissue disorder—Epirubicin—liver cancer	0.000341	0.00123	CcSEcCtD
Hydromorphone—Urethral disorder—Epirubicin—liver cancer	0.000341	0.00122	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Doxorubicin—liver cancer	0.000339	0.00122	CcSEcCtD
Hydromorphone—Visual impairment—Epirubicin—liver cancer	0.000335	0.0012	CcSEcCtD
Hydromorphone—Bradycardia—Doxorubicin—liver cancer	0.000327	0.00118	CcSEcCtD
Hydromorphone—Eye disorder—Epirubicin—liver cancer	0.000325	0.00117	CcSEcCtD
Hydromorphone—Tinnitus—Epirubicin—liver cancer	0.000324	0.00117	CcSEcCtD
Hydromorphone—Flushing—Epirubicin—liver cancer	0.000322	0.00116	CcSEcCtD
Hydromorphone—Cardiac disorder—Epirubicin—liver cancer	0.000322	0.00116	CcSEcCtD
Hydromorphone—Rhinitis—Doxorubicin—liver cancer	0.000322	0.00116	CcSEcCtD
Hydromorphone—Dextromethorphan—CYP2E1—liver cancer	0.000321	0.284	CrCbGaD
Hydromorphone—Hypoaesthesia—Doxorubicin—liver cancer	0.00032	0.00115	CcSEcCtD
Hydromorphone—Urinary tract disorder—Doxorubicin—liver cancer	0.000317	0.00114	CcSEcCtD
Hydromorphone—Oedema peripheral—Doxorubicin—liver cancer	0.000317	0.00114	CcSEcCtD
Hydromorphone—Connective tissue disorder—Doxorubicin—liver cancer	0.000316	0.00114	CcSEcCtD
Hydromorphone—Angiopathy—Epirubicin—liver cancer	0.000315	0.00113	CcSEcCtD
Hydromorphone—Urethral disorder—Doxorubicin—liver cancer	0.000315	0.00113	CcSEcCtD
Hydromorphone—Immune system disorder—Epirubicin—liver cancer	0.000314	0.00113	CcSEcCtD
Hydromorphone—Mediastinal disorder—Epirubicin—liver cancer	0.000313	0.00113	CcSEcCtD
Hydromorphone—Chills—Epirubicin—liver cancer	0.000312	0.00112	CcSEcCtD
Hydromorphone—Arrhythmia—Epirubicin—liver cancer	0.00031	0.00112	CcSEcCtD
Hydromorphone—Visual impairment—Doxorubicin—liver cancer	0.00031	0.00111	CcSEcCtD
Hydromorphone—Mental disorder—Epirubicin—liver cancer	0.000304	0.00109	CcSEcCtD
Hydromorphone—Erythema—Epirubicin—liver cancer	0.000302	0.00109	CcSEcCtD
Hydromorphone—Malnutrition—Epirubicin—liver cancer	0.000302	0.00109	CcSEcCtD
Hydromorphone—Eye disorder—Doxorubicin—liver cancer	0.0003	0.00108	CcSEcCtD
Hydromorphone—Tinnitus—Doxorubicin—liver cancer	0.0003	0.00108	CcSEcCtD
Hydromorphone—Flushing—Doxorubicin—liver cancer	0.000298	0.00107	CcSEcCtD
Hydromorphone—Cardiac disorder—Doxorubicin—liver cancer	0.000298	0.00107	CcSEcCtD
Hydromorphone—Flatulence—Epirubicin—liver cancer	0.000298	0.00107	CcSEcCtD
Hydromorphone—Tension—Epirubicin—liver cancer	0.000297	0.00107	CcSEcCtD
Hydromorphone—Dysgeusia—Epirubicin—liver cancer	0.000296	0.00107	CcSEcCtD
Hydromorphone—Nervousness—Epirubicin—liver cancer	0.000294	0.00106	CcSEcCtD
Hydromorphone—Back pain—Epirubicin—liver cancer	0.000293	0.00105	CcSEcCtD
Hydromorphone—Angiopathy—Doxorubicin—liver cancer	0.000292	0.00105	CcSEcCtD
Hydromorphone—Muscle spasms—Epirubicin—liver cancer	0.000291	0.00105	CcSEcCtD
Hydromorphone—Immune system disorder—Doxorubicin—liver cancer	0.00029	0.00104	CcSEcCtD
Hydromorphone—Mediastinal disorder—Doxorubicin—liver cancer	0.00029	0.00104	CcSEcCtD
Hydromorphone—Chills—Doxorubicin—liver cancer	0.000288	0.00104	CcSEcCtD
Hydromorphone—Arrhythmia—Doxorubicin—liver cancer	0.000287	0.00103	CcSEcCtD
Hydromorphone—Vision blurred—Epirubicin—liver cancer	0.000285	0.00103	CcSEcCtD
Hydromorphone—Mental disorder—Doxorubicin—liver cancer	0.000282	0.00101	CcSEcCtD
Hydromorphone—Ill-defined disorder—Epirubicin—liver cancer	0.000281	0.00101	CcSEcCtD
Hydromorphone—Malnutrition—Doxorubicin—liver cancer	0.00028	0.00101	CcSEcCtD
Hydromorphone—Erythema—Doxorubicin—liver cancer	0.00028	0.00101	CcSEcCtD
Hydromorphone—Agitation—Epirubicin—liver cancer	0.000278	0.001	CcSEcCtD
Hydromorphone—Flatulence—Doxorubicin—liver cancer	0.000276	0.000992	CcSEcCtD
Hydromorphone—Tension—Doxorubicin—liver cancer	0.000275	0.000988	CcSEcCtD
Hydromorphone—Dysgeusia—Doxorubicin—liver cancer	0.000274	0.000986	CcSEcCtD
Hydromorphone—Malaise—Epirubicin—liver cancer	0.000273	0.000981	CcSEcCtD
Hydromorphone—Nervousness—Doxorubicin—liver cancer	0.000272	0.000978	CcSEcCtD
Hydromorphone—Vertigo—Epirubicin—liver cancer	0.000272	0.000977	CcSEcCtD
Hydromorphone—Syncope—Epirubicin—liver cancer	0.000271	0.000976	CcSEcCtD
Hydromorphone—Leukopenia—Epirubicin—liver cancer	0.000271	0.000974	CcSEcCtD
Hydromorphone—Back pain—Doxorubicin—liver cancer	0.000271	0.000974	CcSEcCtD
Hydromorphone—Muscle spasms—Doxorubicin—liver cancer	0.000269	0.000968	CcSEcCtD
Hydromorphone—Palpitations—Epirubicin—liver cancer	0.000267	0.000961	CcSEcCtD
Hydromorphone—Loss of consciousness—Epirubicin—liver cancer	0.000266	0.000956	CcSEcCtD
Hydromorphone—Cough—Epirubicin—liver cancer	0.000264	0.000949	CcSEcCtD
Hydromorphone—Vision blurred—Doxorubicin—liver cancer	0.000264	0.000949	CcSEcCtD
Hydromorphone—Convulsion—Epirubicin—liver cancer	0.000262	0.000943	CcSEcCtD
Hydromorphone—Hypertension—Epirubicin—liver cancer	0.000261	0.000939	CcSEcCtD
Hydromorphone—Ill-defined disorder—Doxorubicin—liver cancer	0.00026	0.000934	CcSEcCtD
Hydromorphone—Arthralgia—Epirubicin—liver cancer	0.000257	0.000926	CcSEcCtD
Hydromorphone—Myalgia—Epirubicin—liver cancer	0.000257	0.000926	CcSEcCtD
Hydromorphone—Chest pain—Epirubicin—liver cancer	0.000257	0.000926	CcSEcCtD
Hydromorphone—Agitation—Doxorubicin—liver cancer	0.000257	0.000925	CcSEcCtD
Hydromorphone—Anxiety—Epirubicin—liver cancer	0.000257	0.000923	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000256	0.00092	CcSEcCtD
Hydromorphone—Discomfort—Epirubicin—liver cancer	0.000254	0.000915	CcSEcCtD
Hydromorphone—Malaise—Doxorubicin—liver cancer	0.000252	0.000908	CcSEcCtD
Hydromorphone—Dry mouth—Epirubicin—liver cancer	0.000252	0.000906	CcSEcCtD
Hydromorphone—Vertigo—Doxorubicin—liver cancer	0.000251	0.000904	CcSEcCtD
Hydromorphone—Syncope—Doxorubicin—liver cancer	0.000251	0.000903	CcSEcCtD
Hydromorphone—Leukopenia—Doxorubicin—liver cancer	0.00025	0.000901	CcSEcCtD
Hydromorphone—Confusional state—Epirubicin—liver cancer	0.000249	0.000895	CcSEcCtD
Hydromorphone—Naloxone—ALB—liver cancer	0.000249	0.22	CrCbGaD
Hydromorphone—Palpitations—Doxorubicin—liver cancer	0.000247	0.000889	CcSEcCtD
Hydromorphone—Anaphylactic shock—Epirubicin—liver cancer	0.000247	0.000888	CcSEcCtD
Hydromorphone—Loss of consciousness—Doxorubicin—liver cancer	0.000246	0.000885	CcSEcCtD
Hydromorphone—Infection—Epirubicin—liver cancer	0.000245	0.000882	CcSEcCtD
Hydromorphone—Cough—Doxorubicin—liver cancer	0.000244	0.000878	CcSEcCtD
Hydromorphone—Shock—Epirubicin—liver cancer	0.000243	0.000873	CcSEcCtD
Hydromorphone—Convulsion—Doxorubicin—liver cancer	0.000242	0.000872	CcSEcCtD
Hydromorphone—Nervous system disorder—Epirubicin—liver cancer	0.000242	0.000871	CcSEcCtD
Hydromorphone—Hypertension—Doxorubicin—liver cancer	0.000242	0.000869	CcSEcCtD
Hydromorphone—Tachycardia—Epirubicin—liver cancer	0.000241	0.000866	CcSEcCtD
Hydromorphone—Skin disorder—Epirubicin—liver cancer	0.00024	0.000862	CcSEcCtD
Hydromorphone—Hyperhidrosis—Epirubicin—liver cancer	0.000239	0.000858	CcSEcCtD
Hydromorphone—Chest pain—Doxorubicin—liver cancer	0.000238	0.000857	CcSEcCtD
Hydromorphone—Arthralgia—Doxorubicin—liver cancer	0.000238	0.000857	CcSEcCtD
Hydromorphone—Myalgia—Doxorubicin—liver cancer	0.000238	0.000857	CcSEcCtD
Hydromorphone—Anxiety—Doxorubicin—liver cancer	0.000237	0.000854	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000237	0.000851	CcSEcCtD
Hydromorphone—Discomfort—Doxorubicin—liver cancer	0.000235	0.000847	CcSEcCtD
Hydromorphone—Anorexia—Epirubicin—liver cancer	0.000235	0.000846	CcSEcCtD
Hydromorphone—Dry mouth—Doxorubicin—liver cancer	0.000233	0.000838	CcSEcCtD
Hydromorphone—Hypotension—Epirubicin—liver cancer	0.000231	0.00083	CcSEcCtD
Hydromorphone—Confusional state—Doxorubicin—liver cancer	0.00023	0.000828	CcSEcCtD
Hydromorphone—Anaphylactic shock—Doxorubicin—liver cancer	0.000228	0.000821	CcSEcCtD
Hydromorphone—Infection—Doxorubicin—liver cancer	0.000227	0.000816	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000225	0.000809	CcSEcCtD
Hydromorphone—Shock—Doxorubicin—liver cancer	0.000225	0.000808	CcSEcCtD
Hydromorphone—Nervous system disorder—Doxorubicin—liver cancer	0.000224	0.000806	CcSEcCtD
Hydromorphone—Insomnia—Epirubicin—liver cancer	0.000223	0.000803	CcSEcCtD
Hydromorphone—Tachycardia—Doxorubicin—liver cancer	0.000223	0.000802	CcSEcCtD
Hydromorphone—Skin disorder—Doxorubicin—liver cancer	0.000222	0.000798	CcSEcCtD
Hydromorphone—Paraesthesia—Epirubicin—liver cancer	0.000222	0.000797	CcSEcCtD
Hydromorphone—Hyperhidrosis—Doxorubicin—liver cancer	0.000221	0.000794	CcSEcCtD
Hydromorphone—Dyspnoea—Epirubicin—liver cancer	0.00022	0.000792	CcSEcCtD
Hydromorphone—Somnolence—Epirubicin—liver cancer	0.000219	0.000789	CcSEcCtD
Hydromorphone—Anorexia—Doxorubicin—liver cancer	0.000218	0.000783	CcSEcCtD
Hydromorphone—Dyspepsia—Epirubicin—liver cancer	0.000217	0.000781	CcSEcCtD
Hydromorphone—Decreased appetite—Epirubicin—liver cancer	0.000215	0.000772	CcSEcCtD
Hydromorphone—Hypotension—Doxorubicin—liver cancer	0.000213	0.000768	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000213	0.000766	CcSEcCtD
Hydromorphone—Fatigue—Epirubicin—liver cancer	0.000213	0.000765	CcSEcCtD
Hydromorphone—Pain—Epirubicin—liver cancer	0.000211	0.000759	CcSEcCtD
Hydromorphone—Constipation—Epirubicin—liver cancer	0.000211	0.000759	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000208	0.000748	CcSEcCtD
Hydromorphone—Insomnia—Doxorubicin—liver cancer	0.000207	0.000743	CcSEcCtD
Hydromorphone—Paraesthesia—Doxorubicin—liver cancer	0.000205	0.000738	CcSEcCtD
Hydromorphone—Dyspnoea—Doxorubicin—liver cancer	0.000204	0.000732	CcSEcCtD
Hydromorphone—Feeling abnormal—Epirubicin—liver cancer	0.000203	0.000732	CcSEcCtD
Hydromorphone—Somnolence—Doxorubicin—liver cancer	0.000203	0.00073	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Epirubicin—liver cancer	0.000202	0.000726	CcSEcCtD
Hydromorphone—Dyspepsia—Doxorubicin—liver cancer	0.000201	0.000723	CcSEcCtD
Hydromorphone—Decreased appetite—Doxorubicin—liver cancer	0.000199	0.000714	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000197	0.000709	CcSEcCtD
Hydromorphone—Fatigue—Doxorubicin—liver cancer	0.000197	0.000708	CcSEcCtD
Hydromorphone—Urticaria—Epirubicin—liver cancer	0.000196	0.000705	CcSEcCtD
Hydromorphone—Pain—Doxorubicin—liver cancer	0.000195	0.000702	CcSEcCtD
Hydromorphone—Constipation—Doxorubicin—liver cancer	0.000195	0.000702	CcSEcCtD
Hydromorphone—Abdominal pain—Epirubicin—liver cancer	0.000195	0.000702	CcSEcCtD
Hydromorphone—Body temperature increased—Epirubicin—liver cancer	0.000195	0.000702	CcSEcCtD
Hydromorphone—Feeling abnormal—Doxorubicin—liver cancer	0.000188	0.000677	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000187	0.000672	CcSEcCtD
Hydromorphone—Hypersensitivity—Epirubicin—liver cancer	0.000182	0.000654	CcSEcCtD
Hydromorphone—Urticaria—Doxorubicin—liver cancer	0.000181	0.000653	CcSEcCtD
Hydromorphone—Abdominal pain—Doxorubicin—liver cancer	0.000181	0.000649	CcSEcCtD
Hydromorphone—Body temperature increased—Doxorubicin—liver cancer	0.000181	0.000649	CcSEcCtD
Hydromorphone—Asthenia—Epirubicin—liver cancer	0.000177	0.000637	CcSEcCtD
Hydromorphone—Pruritus—Epirubicin—liver cancer	0.000175	0.000628	CcSEcCtD
Hydromorphone—Diarrhoea—Epirubicin—liver cancer	0.000169	0.000607	CcSEcCtD
Hydromorphone—Hypersensitivity—Doxorubicin—liver cancer	0.000168	0.000605	CcSEcCtD
Hydromorphone—Asthenia—Doxorubicin—liver cancer	0.000164	0.000589	CcSEcCtD
Hydromorphone—Dizziness—Epirubicin—liver cancer	0.000163	0.000587	CcSEcCtD
Hydromorphone—Pruritus—Doxorubicin—liver cancer	0.000162	0.000581	CcSEcCtD
Hydromorphone—Vomiting—Epirubicin—liver cancer	0.000157	0.000564	CcSEcCtD
Hydromorphone—Diarrhoea—Doxorubicin—liver cancer	0.000156	0.000562	CcSEcCtD
Hydromorphone—Rash—Epirubicin—liver cancer	0.000156	0.00056	CcSEcCtD
Hydromorphone—Dermatitis—Epirubicin—liver cancer	0.000155	0.000559	CcSEcCtD
Hydromorphone—Headache—Epirubicin—liver cancer	0.000155	0.000556	CcSEcCtD
Hydromorphone—Dizziness—Doxorubicin—liver cancer	0.000151	0.000543	CcSEcCtD
Hydromorphone—Nausea—Epirubicin—liver cancer	0.000147	0.000527	CcSEcCtD
Hydromorphone—Vomiting—Doxorubicin—liver cancer	0.000145	0.000522	CcSEcCtD
Hydromorphone—Rash—Doxorubicin—liver cancer	0.000144	0.000518	CcSEcCtD
Hydromorphone—Dermatitis—Doxorubicin—liver cancer	0.000144	0.000517	CcSEcCtD
Hydromorphone—Headache—Doxorubicin—liver cancer	0.000143	0.000515	CcSEcCtD
Hydromorphone—Nausea—Doxorubicin—liver cancer	0.000136	0.000488	CcSEcCtD
Hydromorphone—OPRK1—Signaling Pathways—CSF2—liver cancer	3.34e-05	0.000214	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—RAF1—liver cancer	3.33e-05	0.000213	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP1A1—liver cancer	3.31e-05	0.000212	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—H2AFX—liver cancer	3.29e-05	0.00021	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—IL2—liver cancer	3.29e-05	0.00021	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTA4—liver cancer	3.28e-05	0.00021	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTA4—liver cancer	3.26e-05	0.000208	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CB—liver cancer	3.25e-05	0.000208	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTA2—liver cancer	3.2e-05	0.000205	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PRKCE—liver cancer	3.19e-05	0.000204	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.18e-05	0.000204	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTA2—liver cancer	3.17e-05	0.000203	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CD—liver cancer	3.15e-05	0.000202	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KDR—liver cancer	3.1e-05	0.000199	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTP1—liver cancer	3.09e-05	0.000198	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTA1—liver cancer	3.09e-05	0.000198	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—MTHFR—liver cancer	3.08e-05	0.000197	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK14—liver cancer	3.08e-05	0.000197	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTA1—liver cancer	3.06e-05	0.000196	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NAT2—liver cancer	3.05e-05	0.000195	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—HMOX1—liver cancer	3.05e-05	0.000195	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NAT2—liver cancer	3.03e-05	0.000194	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CB—liver cancer	3.02e-05	0.000194	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PPARA—liver cancer	3.02e-05	0.000194	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ESR1—liver cancer	3.02e-05	0.000193	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF2—liver cancer	3.02e-05	0.000193	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—F2—liver cancer	2.99e-05	0.000191	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL2—liver cancer	2.98e-05	0.000191	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TERT—liver cancer	2.97e-05	0.00019	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALDOB—liver cancer	2.93e-05	0.000187	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.91e-05	0.000186	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALDOB—liver cancer	2.9e-05	0.000186	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—APC—liver cancer	2.86e-05	0.000183	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CG—liver cancer	2.86e-05	0.000183	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTM1—liver cancer	2.84e-05	0.000182	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CSF2—liver cancer	2.82e-05	0.00018	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—RAF1—liver cancer	2.81e-05	0.00018	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CRABP1—liver cancer	2.79e-05	0.000179	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—H2AFX—liver cancer	2.78e-05	0.000178	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—IL2—liver cancer	2.78e-05	0.000178	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CRABP1—liver cancer	2.77e-05	0.000177	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CB—liver cancer	2.75e-05	0.000176	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KDR—liver cancer	2.72e-05	0.000174	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.72e-05	0.000174	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK14—liver cancer	2.7e-05	0.000173	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP1A1—liver cancer	2.7e-05	0.000172	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—BRAF—liver cancer	2.69e-05	0.000172	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ESR1—liver cancer	2.65e-05	0.00017	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—F2—liver cancer	2.62e-05	0.000168	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CG—liver cancer	2.59e-05	0.000166	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL2—liver cancer	2.52e-05	0.000161	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TERT—liver cancer	2.51e-05	0.000161	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—MTHFR—liver cancer	2.51e-05	0.000161	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CD—liver cancer	2.51e-05	0.000161	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—APC—liver cancer	2.51e-05	0.00016	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CG—liver cancer	2.51e-05	0.00016	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PPARG—liver cancer	2.5e-05	0.00016	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.49e-05	0.000159	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—PIK3CA—liver cancer	2.49e-05	0.000159	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SERPINE1—liver cancer	2.48e-05	0.000159	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CPT1B—liver cancer	2.48e-05	0.000158	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GLUL—liver cancer	2.48e-05	0.000158	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PPARA—liver cancer	2.46e-05	0.000158	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—KRAS—liver cancer	2.46e-05	0.000157	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HPGDS—liver cancer	2.44e-05	0.000156	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HPGDS—liver cancer	2.42e-05	0.000155	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.41e-05	0.000154	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NR1H4—liver cancer	2.39e-05	0.000153	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—BRAF—liver cancer	2.35e-05	0.000151	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTA3—liver cancer	2.35e-05	0.00015	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KDR—liver cancer	2.3e-05	0.000147	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK14—liver cancer	2.28e-05	0.000146	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CD—liver cancer	2.28e-05	0.000146	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PIK3CA—liver cancer	2.26e-05	0.000145	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—liver cancer	2.25e-05	0.000144	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RAF1—liver cancer	2.24e-05	0.000144	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ESR1—liver cancer	2.24e-05	0.000143	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.21e-05	0.000142	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—F2—liver cancer	2.21e-05	0.000142	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CD—liver cancer	2.2e-05	0.000141	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.19e-05	0.00014	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MTOR—liver cancer	2.19e-05	0.00014	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CB—liver cancer	2.19e-05	0.00014	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—PIK3CA—liver cancer	2.18e-05	0.00014	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SERPINE1—liver cancer	2.18e-05	0.000139	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PSMD10—liver cancer	2.18e-05	0.000139	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PSMA4—liver cancer	2.18e-05	0.000139	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.16e-05	0.000138	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—KRAS—liver cancer	2.16e-05	0.000138	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PSMD10—liver cancer	2.16e-05	0.000138	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PSMA4—liver cancer	2.16e-05	0.000138	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTA4—liver cancer	2.15e-05	0.000137	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APC—liver cancer	2.12e-05	0.000136	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CG—liver cancer	2.12e-05	0.000136	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GOT2—liver cancer	2.12e-05	0.000135	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CG—liver cancer	2.11e-05	0.000135	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GOT2—liver cancer	2.1e-05	0.000134	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTA2—liver cancer	2.09e-05	0.000134	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—HRAS—liver cancer	2.09e-05	0.000134	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1B—liver cancer	2.05e-05	0.000131	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PPARG—liver cancer	2.04e-05	0.00013	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AKT1—liver cancer	2.03e-05	0.00013	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTA1—liver cancer	2.02e-05	0.000129	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CASP3—liver cancer	2.01e-05	0.000129	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—liver cancer	2.01e-05	0.000129	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—liver cancer	2e-05	0.000128	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NAT2—liver cancer	2e-05	0.000128	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—BRAF—liver cancer	1.99e-05	0.000127	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP2E1—liver cancer	1.99e-05	0.000127	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CB—liver cancer	1.98e-05	0.000127	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CA—liver cancer	1.98e-05	0.000127	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP2E1—liver cancer	1.97e-05	0.000126	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RAF1—liver cancer	1.97e-05	0.000126	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—liver cancer	1.96e-05	0.000125	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—JUN—liver cancer	1.96e-05	0.000125	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CTNNB1—liver cancer	1.94e-05	0.000124	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CB—liver cancer	1.92e-05	0.000123	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MTOR—liver cancer	1.92e-05	0.000123	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDOB—liver cancer	1.91e-05	0.000122	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.91e-05	0.000122	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MMP9—liver cancer	1.9e-05	0.000122	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1A—liver cancer	1.9e-05	0.000121	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CD—liver cancer	1.86e-05	0.000119	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYCS—liver cancer	1.86e-05	0.000119	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CD—liver cancer	1.86e-05	0.000119	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK8—liver cancer	1.85e-05	0.000118	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AKT1—liver cancer	1.85e-05	0.000118	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYCS—liver cancer	1.85e-05	0.000118	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.84e-05	0.000118	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SERPINE1—liver cancer	1.84e-05	0.000118	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—HRAS—liver cancer	1.83e-05	0.000117	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—liver cancer	1.83e-05	0.000117	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GOT1—liver cancer	1.83e-05	0.000117	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GGT1—liver cancer	1.83e-05	0.000117	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CRABP1—liver cancer	1.83e-05	0.000117	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—KRAS—liver cancer	1.82e-05	0.000117	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GGT1—liver cancer	1.81e-05	0.000116	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GOT1—liver cancer	1.81e-05	0.000116	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1B—liver cancer	1.8e-05	0.000115	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AKT1—liver cancer	1.78e-05	0.000114	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CASP3—liver cancer	1.77e-05	0.000113	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—liver cancer	1.76e-05	0.000113	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—liver cancer	1.75e-05	0.000112	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—liver cancer	1.72e-05	0.00011	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JUN—liver cancer	1.72e-05	0.00011	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—liver cancer	1.71e-05	0.000109	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CTNNB1—liver cancer	1.7e-05	0.000109	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STAT3—liver cancer	1.69e-05	0.000108	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	1.67e-05	0.000107	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MMP9—liver cancer	1.67e-05	0.000107	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1A—liver cancer	1.66e-05	0.000106	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RAF1—liver cancer	1.66e-05	0.000106	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTP1—liver cancer	1.64e-05	0.000105	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTP1—liver cancer	1.63e-05	0.000104	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK8—liver cancer	1.62e-05	0.000104	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MTOR—liver cancer	1.62e-05	0.000104	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CB—liver cancer	1.62e-05	0.000104	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AKT1—liver cancer	1.62e-05	0.000104	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMOX1—liver cancer	1.62e-05	0.000104	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CB—liver cancer	1.62e-05	0.000104	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMOX1—liver cancer	1.6e-05	0.000103	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HPGDS—liver cancer	1.6e-05	0.000102	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MYC—liver cancer	1.57e-05	0.000101	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TGFB1—liver cancer	1.57e-05	0.0001	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—HRAS—liver cancer	1.55e-05	9.91e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1B—liver cancer	1.52e-05	9.75e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—liver cancer	1.51e-05	9.65e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AKT1—liver cancer	1.51e-05	9.64e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—liver cancer	1.5e-05	9.59e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—liver cancer	1.49e-05	9.57e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CASP3—liver cancer	1.49e-05	9.55e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—liver cancer	1.49e-05	9.54e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STAT3—liver cancer	1.48e-05	9.5e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—liver cancer	1.48e-05	9.49e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KRAS—liver cancer	1.45e-05	9.3e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—liver cancer	1.45e-05	9.3e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JUN—liver cancer	1.45e-05	9.28e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CTNNB1—liver cancer	1.44e-05	9.21e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1A1—liver cancer	1.43e-05	9.15e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PSMA4—liver cancer	1.42e-05	9.1e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PSMD10—liver cancer	1.42e-05	9.1e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1A1—liver cancer	1.42e-05	9.07e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP9—liver cancer	1.41e-05	9.03e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1A—liver cancer	1.41e-05	8.99e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GOT2—liver cancer	1.38e-05	8.85e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MYC—liver cancer	1.38e-05	8.82e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TGFB1—liver cancer	1.38e-05	8.8e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK8—liver cancer	1.37e-05	8.78e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AKT1—liver cancer	1.37e-05	8.75e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CA—liver cancer	1.33e-05	8.54e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MTHFR—liver cancer	1.33e-05	8.53e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MTHFR—liver cancer	1.32e-05	8.45e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARA—liver cancer	1.31e-05	8.37e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2E1—liver cancer	1.3e-05	8.32e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARA—liver cancer	1.3e-05	8.29e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—liver cancer	1.29e-05	8.26e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KRAS—liver cancer	1.27e-05	8.15e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—liver cancer	1.27e-05	8.1e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STAT3—liver cancer	1.25e-05	8.02e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HRAS—liver cancer	1.23e-05	7.9e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYCS—liver cancer	1.22e-05	7.79e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CA—liver cancer	1.21e-05	7.74e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GOT1—liver cancer	1.19e-05	7.64e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GGT1—liver cancer	1.19e-05	7.64e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—liver cancer	1.18e-05	7.56e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CA—liver cancer	1.17e-05	7.49e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MYC—liver cancer	1.17e-05	7.46e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.16e-05	7.45e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TGFB1—liver cancer	1.16e-05	7.44e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—liver cancer	1.13e-05	7.25e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CG—liver cancer	1.12e-05	7.16e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CG—liver cancer	1.11e-05	7.1e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT1—liver cancer	1.09e-05	6.98e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HRAS—liver cancer	1.08e-05	6.93e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARG—liver cancer	1.08e-05	6.91e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KRAS—liver cancer	1.08e-05	6.89e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTP1—liver cancer	1.07e-05	6.86e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARG—liver cancer	1.07e-05	6.86e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMOX1—liver cancer	1.06e-05	6.77e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—liver cancer	1.04e-05	6.63e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CA—liver cancer	9.89e-06	6.33e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKT1—liver cancer	9.88e-06	6.32e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CA—liver cancer	9.86e-06	6.31e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—liver cancer	9.86e-06	6.31e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CD—liver cancer	9.84e-06	6.3e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CD—liver cancer	9.76e-06	6.24e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—liver cancer	9.71e-06	6.22e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—liver cancer	9.63e-06	6.16e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—liver cancer	9.57e-06	6.12e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT1—liver cancer	9.56e-06	6.12e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1A1—liver cancer	9.34e-06	5.98e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HRAS—liver cancer	9.15e-06	5.86e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—liver cancer	8.76e-06	5.61e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTHFR—liver cancer	8.71e-06	5.58e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CB—liver cancer	8.58e-06	5.49e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARA—liver cancer	8.55e-06	5.47e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CB—liver cancer	8.5e-06	5.44e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT1—liver cancer	8.08e-06	5.17e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKT1—liver cancer	8.06e-06	5.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CG—liver cancer	7.32e-06	4.68e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARG—liver cancer	7.06e-06	4.52e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CD—liver cancer	6.43e-06	4.12e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—liver cancer	6.35e-06	4.07e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CB—liver cancer	5.61e-06	3.59e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CA—liver cancer	5.23e-06	3.35e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CA—liver cancer	5.18e-06	3.32e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKT1—liver cancer	4.27e-06	2.73e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKT1—liver cancer	4.23e-06	2.71e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CA—liver cancer	3.42e-06	2.19e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKT1—liver cancer	2.79e-06	1.79e-05	CbGpPWpGaD
